Release date: 2015-10-22 “The capital market has arrived in the winter.†At various O2O summits, both investors and entrepreneurs have reached this conclusion through personal experience. With the continued turmoil in the world's major stock markets, domestic VCs have become more cautious, pouring a cold water on the current booming entrepreneurial tide. In the past few months, the frequency of O2O corporate financing has been greatly reduced. The once-malicious financing declaration has become a dead letter, but the giants are not affected. In this context, the emerging O2O companies are facing the test of life and death. How to grasp the life-saving straw in the raging wave, O2O companies have their own voices. Compared with other O2O industries that are in a difficult situation, pharmaceutical O2O seems to be immune to cold waves. Recently, O2O, such as registered network and interesting medical network, received financing in succession. The intervention of giants such as Alibaba, JD.com and Ping An Group also ignited a fire for medical O2O. However, the seemingly high amount of financing is actually a drop in the bucket compared to the actual demand. The pharmaceutical industry is greatly affected by policies and institutions, and there is still a long way to go to realize real mobile medical care. Frequency financing While other O2O companies have just smelled a bit of cool autumn, the medical O2O has been exposed to good news. Since September, China Mobile Network, Medical Network and Fun Medical Network have successively obtained financing, and the financing amount has exceeded 10 million US dollars. Among them, the 394 million US dollars C round of financing of registered network has refreshed the financing record of medical O2O. In addition to investment giants such as Gaochun Capital and Fuxing, the investor also includes Tencent, one of the three BAT giants. In addition to the previous Alibaba's Ali Health, Ping An Group's heavy money to build a safe doctor, Shanghai Pharmaceutical and Jingdong jointly invested in the drug cloud health, etc., medical O2O has become a feast of capital and giants. The financing of subdivided medical fields such as palm sugar medicine and good pregnancy help also envied other industries. Some insiders joked that "medical O2O is like spring in the cold night of capital." However, a recent article about Dr. Chun Yu's Oolong article detonated the circle of medicine O2O. The article titled "On the Fall of Dr. Chun Yu", although the author and Dr. Chun Yu promptly blame, but it also reflects the medical O2O Great controversy and dilemma. According to Tan Yong, executive editor of the medical magazine, the farce is actually not related to Dr. Chun Yu, reflecting that the public has lost patience with Internet medical care: no matter how good or bad, please give me a statement. Different from other O2O companies, most of the mainstream medicine O2O has a medical background and has a long accumulation. Registered network, Chun Yu doctor was established around 2010, the clove garden can be traced back to 2000. However, in the industry's view, due to policies, institutions and bottom-notch investment, mobile medical care has not been substantially developed, and the short-term hot is difficult to cover the long-term winter. Hard to find Medicine O2O has been exemplified abroad, but the completely different national conditions in China have made it difficult to promote O2O. The dilemma of the development of the industry lies in the small medical market, the resistance of the unified market and the long period of trust training. Ni Jianwen, vice president of Ali Health, said that medicine O2O has a high degree of enthusiasm. In the era of entrepreneurship, entrepreneurs can form a team with high entrepreneurial enthusiasm and get capital support. The health care reform policy has also allowed the development of pharmaceutical O2O. However, the three walls of medical, medical and medical insurance still hinder the development of the industry. "The hospital's core system is not open to the outside world, so it is difficult for medical treatment to move. It is still meaningless to move medicine only, but it is still meaningless. Before the prescription drug is released, the patient can go to the hospital to take medicine after seeing the doctor through mobile medical treatment, then everything in front In addition, most of the citizens in China are covered by medical insurance, and the medical insurance reimbursement problem cannot be solved. The medical O2O is meaningless." A senior industry expert believes that doctors are the basic resource in mobile medicine. Only by building a good doctor network community to develop a stable group of doctors, so that doctors can actually benefit from the Internet, can mobile medical care be realized, but this requires long-term breeding and huge investment. Breaking the force Driven by fiery capital, the pharmaceutical O2O industry will move to a new height, but this is not something that can be done overnight. The introduction of a favorable new medical reform policy will bring leap to the industry. Prior to this, companies developed their own tacit understanding, and the smell of gunpowder was not strong. "Although the company has friction, it has not started to burn money like other fields. Because everyone understands that there is no point in playing now." The above-mentioned industry experts said that the enemy of medical O2O is not a competitor, but an old one. System, cultivate new habits. However, due to the particularity of the industry, the habits of consumers and service providers can be achieved without relying on simple burning of money. The development of the industry requires long-term joint promotion. Ni Jianwen said that the real mobile medical care has just started, even if it is BAT, mobile medical has not yet landed, still in the process of exploration. Ali Health has launched medical products such as telemedicine and family doctors in the medical field to improve the advancement of doctors and patients. Tmall Pharmacy also cooperates with pharmacies to prepare prescription drugs, and only the online prescription drug policy is introduced. In the industry's view, as an e-commerce giant, Tmall's test of water will promote the industry to standardize development. Source: Beijing Business Daily Shower Gel,Shower Cream,Shower Foam,Body Shower Gel Wuxi Keni Daily Cosmetics Co.,Ltd , https://www.wxkenidaily.com